Author: Ken Dropiewski

First Coast Cardiovascular Institute Announces Partnership With Cardiovascular Logistics

JACKSONVILLE, Fla.–(BUSINESS WIRE)–First Coast Cardiovascular Institute (FCCI) announced today that it is partnering with national cardiology platform, Cardiovascular Logistics (CVL), to enhance and expand its cardiovascular care and services throughout Northern Florida & Southern Georgia. CVL is the most comprehensive cardiovascular platform in the country. By partnering with CVL, FCCI […]

CWRU and UH researchers secure $6.2 million from NIH to investigate using artificial intelligence to predict cardiovascular disease

Researchers from Case Western Reserve University and University Hospitals Cleveland Medical Center (UH) have secured $6.2 million from two grants awarded in the same month from the National Institutes of Health (NIH) to predict cardiovascular disease through new artificial intelligence (AI) approaches. The study will employ cutting-edge AI techniques using machine- and deep-learning models to recognize […]

Semler Scientific Announces Appointment of Eric Semler and William Chang as Directors

Eric Semler Appointed as Chairman SANTA CLARA, Calif., April 19, 2023 /PRNewswire/ — – Semler Scientific, Inc. (Nasdaq: SMLR) today announced that Eric Semler and William H.C. Chang (together, the “Investors”), who collectively beneficially own more than 20% of Semler Scientific’s outstanding shares, will immediately join Semler Scientific’s board of directors as new independent directors. Mr. Semler […]

Cercare Medical brings their Neurovascular Clinical Workflows into ConcertAI’s TeraRecon Eureka Clinical AI Platform in new Partnership

New partnership incorporates latest perfusion technology into neurological CT and MR imaging CAMBRIDGE, Mass., April 20, 2023 /PRNewswire/ — The Eureka Clinical AI platform from ConcertAI’s TeraRecon provides clinicians with the state-of-the-artand deep learning technologies to deliver next-level CT and MR imaging through Cercare Perfusion, a fully-automated, simple-to-use, patient-specific perfusion software. Brain […]

University of Technology Sydney researchers develop ground-breaking heart failure treatment using 3D-printed heart tissue

New technology enables ‘patches’ of 3D printed tissue to be applied onto the surface of damaged hearts as a safer and more cost-effective alternative to heart transplants. SYDNEY, April 20, 2023 /PRNewswire/ — Researchers from The University of Technology Sydney (UTS) have demonstrated that 3D bioprinted heart tissues can safely and effectively […]

Acutus Medical Announces Preliminary Unaudited First Quarter 2023 Results

CARLSBAD, Calif., April 20, 2023 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced preliminary unaudited results for the first quarter 2023 in addition to the release of the RECOVER […]

RECOVER AF Study Reports 91% of First Redo Patients Achieved Freedom from AF at One Year After AcQMap-guided Ablation Therapy

CARLSBAD, Calif., April 20, 2023 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced results from the RECOVER AF study. The study, published online in EP Europace, found that patients who received AcQMap-guided ablations […]

Windtree Therapeutics Announces Pricing of Upsized $10.8 Million Underwritten Public Offering

WARRINGTON, Pa., April 20, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, today announced the pricing of its underwritten public offering of 3,686,006 shares of common stock and warrants to purchase up to 3,686,006 shares of […]

CytoSorbents’ Pivotal STAR-T Trial Reaches Second Key Milestone With 80 Patients Enrolled

PRINCETON, N.J., April 20, 2023 (GLOBE NEWSWIRE) — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announces that its pivotal STAR-T  (Safe and Timely Antithrombotic Removal – Ticagrelor) randomized, controlled trial has enrolled 80 patients, […]

US Heart & Vascular Announces Partnership with HeartPlace, one of the Largest Cardiovascular Groups in the United States

The HeartPlace partnership represents USHV’s 6th in Texas and 1st in Dallas-Fort Worth. NASHVILLE, Tenn.–(BUSINESS WIRE)–US Heart & Vascular (“USHV”), a leading national provider of support services to cardiovascular physician practices, has partnered with HeartPlace (“HeartPlace”), the largest physician-owned cardiology practice in Texas, focused on all aspects of cardiovascular care. “We […]